AR074514A1 - Derivados de morfina-6-glucuronido, su preparacion y su aplicacion en terapeutica - Google Patents

Derivados de morfina-6-glucuronido, su preparacion y su aplicacion en terapeutica

Info

Publication number
AR074514A1
AR074514A1 ARP090104752A ARP090104752A AR074514A1 AR 074514 A1 AR074514 A1 AR 074514A1 AR P090104752 A ARP090104752 A AR P090104752A AR P090104752 A ARP090104752 A AR P090104752A AR 074514 A1 AR074514 A1 AR 074514A1
Authority
AR
Argentina
Prior art keywords
application
derivatives
preparation
morfina
glucuronido
Prior art date
Application number
ARP090104752A
Other languages
English (en)
Inventor
Claire Trecant
Alain Dlubala
Isabelle Ripoche
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of AR074514A1 publication Critical patent/AR074514A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06Heterocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente solicitud se refiere a derivados de morfina-6-glucurónido de fórmula (1) en la que R1 es un grupo heteroaromático de 5 eslabones eventualmente sustituido con uno o varios sustituyentes elegidos entre átomos de halógeno y los grupos alquilo C1-4, halógeno, hidroxilo, haloalquilo C1-4, haloalcoxi C1-4, alquiloxi C1-4, aril-alquilo C1-4 y arilo, estando dicho grupo arilo eventualmente sustituido con uno o varios grupos elegidos entre los grupos alquilo C1-4, haloalquilo C1-4, hidroxilo y alquiloxi C1-4; en el estado de base o de sal de adición a un ácido así como en el estado de hidrato o de solvato. La presente solicitud se refiere también a su procedimiento de preparación y a su aplicación en terapéutica.
ARP090104752A 2008-12-10 2009-12-09 Derivados de morfina-6-glucuronido, su preparacion y su aplicacion en terapeutica AR074514A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806949A FR2939437B1 (fr) 2008-12-10 2008-12-10 Derives de morphine-6-glucuronide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
AR074514A1 true AR074514A1 (es) 2011-01-19

Family

ID=41031604

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090104752A AR074514A1 (es) 2008-12-10 2009-12-09 Derivados de morfina-6-glucuronido, su preparacion y su aplicacion en terapeutica

Country Status (30)

Country Link
US (1) US8461122B2 (es)
EP (1) EP2376512B1 (es)
JP (1) JP5616356B2 (es)
KR (1) KR20110104486A (es)
CN (1) CN102317301B (es)
AR (1) AR074514A1 (es)
AU (1) AU2009326909B2 (es)
BR (1) BRPI0922733A2 (es)
CA (1) CA2746429A1 (es)
CL (1) CL2011001399A1 (es)
CR (1) CR20110306A (es)
EA (1) EA019053B1 (es)
EC (1) ECSP11011110A (es)
ES (1) ES2468990T3 (es)
FR (1) FR2939437B1 (es)
HK (1) HK1163110A1 (es)
HN (1) HN2011001601A (es)
IL (1) IL213381A (es)
MA (1) MA32952B1 (es)
MX (1) MX2011006252A (es)
MY (1) MY152978A (es)
NI (1) NI201100115A (es)
NZ (1) NZ593344A (es)
PE (1) PE20120260A1 (es)
SG (1) SG172068A1 (es)
TN (1) TN2011000266A1 (es)
TW (1) TW201026312A (es)
UA (1) UA104302C2 (es)
WO (1) WO2010067010A2 (es)
ZA (1) ZA201104305B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103421063B (zh) * 2012-05-23 2016-04-06 宜昌人福药业有限责任公司 一种合成吗啡-6-β-D-葡萄糖醛酸苷的方法
CN111346104B (zh) * 2018-12-21 2022-06-10 宜昌人福药业有限责任公司 一种吗啡-6-葡萄糖醛酸苷透皮给药的药物组合物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766188A (en) 1971-06-28 1973-10-16 Yamanouchi Pharma Co Ltd Carbonyldioxymorphinan derivatives
GB9116909D0 (en) 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
GB2282758A (en) 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
AU723859B2 (en) * 1997-04-14 2000-09-07 Ufc Limited Morphine derivatives
DE69903291T2 (de) 1998-06-06 2003-06-26 Cenes Ltd Synthese von morphin-6-glucuronid
GB0218811D0 (en) * 2002-08-14 2002-09-18 Cenes Ltd Salts of morphine-6-glucuronide
FR2864082B1 (fr) * 2003-12-22 2006-03-10 Synt Em Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur
ES2623362T3 (es) * 2004-05-28 2017-07-11 Human Biomolecular Research Institute Analgésicos metabólicamente estables y medicaciones para el dolor
FR2907121B1 (fr) * 2006-10-12 2012-05-04 Neorphys Nouveaux derives morphiniques

Also Published As

Publication number Publication date
JP5616356B2 (ja) 2014-10-29
CN102317301A (zh) 2012-01-11
TN2011000266A1 (fr) 2012-12-17
KR20110104486A (ko) 2011-09-22
ECSP11011110A (es) 2011-07-29
WO2010067010A3 (fr) 2011-06-30
FR2939437B1 (fr) 2010-12-17
EP2376512A2 (fr) 2011-10-19
MY152978A (en) 2014-12-15
CA2746429A1 (fr) 2010-06-17
WO2010067010A2 (fr) 2010-06-17
IL213381A0 (en) 2011-07-31
FR2939437A1 (fr) 2010-06-11
HK1163110A1 (en) 2012-09-07
EA201170792A1 (ru) 2012-01-30
MX2011006252A (es) 2011-11-04
HN2011001601A (es) 2013-09-16
ES2468990T3 (es) 2014-06-17
IL213381A (en) 2014-02-27
UA104302C2 (ru) 2014-01-27
EA019053B1 (ru) 2013-12-30
AU2009326909A1 (en) 2011-06-30
PE20120260A1 (es) 2012-04-13
EP2376512B1 (fr) 2014-02-26
ZA201104305B (en) 2012-10-31
NI201100115A (es) 2011-12-14
SG172068A1 (en) 2011-07-28
NZ593344A (en) 2013-08-30
US20110301107A1 (en) 2011-12-08
CR20110306A (es) 2011-09-21
US8461122B2 (en) 2013-06-11
JP2012511553A (ja) 2012-05-24
MA32952B1 (fr) 2012-01-02
CN102317301B (zh) 2015-08-26
BRPI0922733A2 (pt) 2016-01-05
TW201026312A (en) 2010-07-16
CL2011001399A1 (es) 2011-10-28
AU2009326909B2 (en) 2016-05-26

Similar Documents

Publication Publication Date Title
ES2624795T3 (es) Derivados de N-(heteroaril)-1-heteroaril-1H-indol-2-carboxamidas, su preparación y su aplicación en terapéutica
HN2009000502A (es) DERIVADOS DE 2- ARIL-6-FENIL-IMIDAZO[ 1,2-a] PIRIDINAS SU PREPARACION Y SU APLICACION EN TERAPEUTICA
CO6280509A2 (es) Derivados de carboxamidas azabiciclicas su preparacion y su aplicacion en terapeutica
HN2010001460A (es) Derivados biciclicos de carboxamidas aza-biciclicas, su preparacion y su aplicacion terapeutica
CO6420337A2 (es) Sales de adición de aminas que contienen grupos hidroxilo y/o carboxílicos con derivados de ácido aminonicotínico como inhibidores de dhodh
CO6251235A2 (es) Compuestos derivados de azetidinas su preparacion y su aplicacion en terapeutica
CO6551713A2 (es) Derivados de difenil -pirazolopiridinas, su preparación y su aplicación como moduladores del receptor nuclear not
CO6341581A2 (es) Derivados de heteroarilo como inhibidores de dgat1
UY32308A (es) Nucleótidos uracil ciclopropílicos
AR066107A1 (es) Derivados de triazolopiridin - carboxamidas y triazolopirimidin-carboxamidas, su preparacion y su aplicacion en terapeutica como inhibidores de la enzimamonoacil glicerol lipasa y composiciones qu los contienen.
ES2626801T3 (es) Compuestos de triazolopiridina como inhibidores de pde10a
AR072803A1 (es) Tetrahidrocinolinas como inhibidores de la 11- beta -hsd1 para la diabetes
BR112013008675A2 (pt) métodos e composições para o tratamento de diabetes e dislipidemia
CU20100157A7 (es) Nuevos derivados dihidroindolonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CO6400145A2 (es) Derivados de 2-piridin-2-il pirazol-3(2h) -ona, su preparción y su aplicación terapeútica
BR112015006370A8 (pt) composto citotóxico, sua mistura e sal farmaceuticamente aceitável, sal/solvente complexo, metal complexo, exceto um com qualquer de fe2+, fer+, co2+, complexo solvente ou pró-fármico, bem como seu uso e composição o compreendendo
AR054033A1 (es) Derivados de triazinas su preparacion y su aplicacion en terapeutica
NI201200026A (es) Octasacáridos n-acilos activadores de los receptores de los fgf, su preparación y su aplicación en terapéutica.
AR074514A1 (es) Derivados de morfina-6-glucuronido, su preparacion y su aplicacion en terapeutica
AR078093A1 (es) Oligosacaridos n- sulfatados activadores de los receptores de los fgf, su preparacion y su aplicacion en terapeutica
CO6190551A2 (es) Derivado de alquilsulfona
CO6390061A2 (es) Derivados de morfina-6-glucuronido, su preparación y su aplicación en terapeutica
CO6251267A2 (es) Derivados de n5-(2-etoxi-etil)-n3-(2-piperidin-dicarboxamida para usarse como inhiibidores de renina
NI201100113A (es) Derivados bicíclicos de morfina - 6 - glucuronido, su preparación y su aplicación en terapeutica.
CR20120071A (es) Octasacáridos n-acilos activadores de los receptores de los fgf, su preparación y su aplicación en terapéutica

Legal Events

Date Code Title Description
FB Suspension of granting procedure